Quick medicine delivery startup Plazza has secured $15 million (approximately ₹145 crore) in a Series A funding round co-led by Accel, Elevation Capital, and Nexus Venture Partners, with participation from existing investors All In Capital and Better Capital.
The fresh capital will be used to strengthen Plazza’s technology platform, enhance its AI-powered inventory and assortment capabilities, expand operational infrastructure, and grow its pharmacy network as the company scales beyond its current footprint in Bengaluru.
Founded in 2024 by former Zomato executive Aman Priyadarshi, Plazza operates technology-enabled neighbourhood pharmacies that deliver medicines within 15 to 30 minutes. The startup currently runs two stores in Bengaluru and plans to expand into more neighbourhoods before entering additional markets.
A key differentiator for Plazza is its inventory strategy. Each store stocks over 40,000 pharmaceutical SKUs, significantly higher than the roughly 5,000 medicines typically available at neighbourhood pharmacies. According to the company, this enables prescription fill rates of more than 95%, compared to an industry average of 50%–60%.
The company uses an AI-powered inventory system that analyses neighbourhood-level demand and local prescription patterns to determine which medicines should be stocked at individual stores. Plazza noted that only about half of the top-selling medicines overlap between its two Bengaluru outlets, highlighting the variation in healthcare demand across different micro-markets.
Unlike conventional pharmacies that primarily serve walk-in customers or e-pharmacies that focus on wider selections with longer delivery timelines, Plazza aims to combine extensive medicine availability with rapid local fulfilment.
Commenting on the funding, founder and CEO Aman Priyadarshi said the investment will help strengthen the intelligence behind every Plazza store, accelerate neighbourhood expansion, and build a pharmacy experience customers can consistently rely on.
Prior to this round, the startup raised $1.4 million from All In Capital and Better Capital in 2025. Plazza also reported that its gross merchandise value (GMV) grew nearly 27 times between June 2025 and March 2026, while repeat customers now spend around 30% more per order than first-time users.
Plazza competes with Tata 1mg, PharmEasy, Netmeds, Apollo Pharmacy, Pillo, and Practo in India’s digital healthcare ecosystem. As quick commerce expands beyond groceries into healthcare, startups are increasingly exploring specialised medicine delivery despite the added complexity of prescription compliance, stricter supply chain requirements, and regulatory oversight. With India’s quick commerce market projected to reach $68 billion in GMV by 2031, Plazza is positioning itself to capture growing demand through faster deliveries, broader medicine availability, and AI-driven inventory management.
Source: Based on publicly available reporting, with additional editorial adaptation and analysis.
